The frequency and outcome of lupus nephritis: results from an international inception cohort study.
dc.contributor.author | Hanly, John G | |
dc.contributor.author | O'Keeffe, Aidan G | |
dc.contributor.author | Su, Li | |
dc.contributor.author | Urowitz, Murray B | |
dc.contributor.author | Romero-Diaz, Juanita | |
dc.contributor.author | Gordon, Caroline | |
dc.contributor.author | Bae, Sang-Cheol | |
dc.contributor.author | Bernatsky, Sasha | |
dc.contributor.author | Clarke, Ann E | |
dc.contributor.author | Wallace, Daniel J | |
dc.contributor.author | Merrill, Joan T | |
dc.contributor.author | Isenberg, David A | |
dc.contributor.author | Rahman, Anisur | |
dc.contributor.author | Ginzler, Ellen M | |
dc.contributor.author | Fortin, Paul | |
dc.contributor.author | Gladman, Dafna D | |
dc.contributor.author | Sanchez-Guerrero, Jorge | |
dc.contributor.author | Petri, Michelle | |
dc.contributor.author | Bruce, Ian N | |
dc.contributor.author | Dooley, Mary Anne | |
dc.contributor.author | Ramsey-Goldman, Rosalind | |
dc.contributor.author | Aranow, Cynthia | |
dc.contributor.author | Alarcón, Graciela S | |
dc.contributor.author | Fessler, Barri J | |
dc.contributor.author | Steinsson, Kristjan | |
dc.contributor.author | Nived, Ola | |
dc.contributor.author | Sturfelt, Gunnar K | |
dc.contributor.author | Manzi, Susan | |
dc.contributor.author | Khamashta, Munther A | |
dc.contributor.author | van Vollenhoven, Ronald F | |
dc.contributor.author | Zoma, Asad A | |
dc.contributor.author | Ramos-Casals, Manuel | |
dc.contributor.author | Ruiz-Irastorza, Guillermo | |
dc.contributor.author | Lim, S Sam | |
dc.contributor.author | Stoll, Thomas | |
dc.contributor.author | Inanc, Murat | |
dc.contributor.author | Kalunian, Kenneth C | |
dc.contributor.author | Kamen, Diane L | |
dc.contributor.author | Maddison, Peter | |
dc.contributor.author | Peschken, Christine A | |
dc.contributor.author | Jacobsen, Soren | |
dc.contributor.author | Askanase, Anca | |
dc.contributor.author | Theriault, Chris | |
dc.contributor.author | Thompson, Kara | |
dc.contributor.author | Farewell, Vernon | |
dc.date.accessioned | 2023-02-07T17:20:24Z | |
dc.date.available | 2023-02-07T17:20:24Z | |
dc.date.issued | 2015-09-05 | |
dc.identifier.citation | Hanly JG, O'Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin P, Gladman DD, Sanchez-Guerrero J, Petri M, Bruce IN, Dooley MA, Ramsey-Goldman R, Aranow C, Alarcón GS, Fessler BJ, Steinsson K, Nived O, Sturfelt GK, Manzi S, Khamashta MA, van Vollenhoven RF, Zoma AA, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Stoll T, Inanc M, Kalunian KC, Kamen DL, Maddison P, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford). 2016 Feb;55(2):252-62. doi: 10.1093/rheumatology/kev311. Epub 2015 Sep 5. PMID: 26342222; PMCID: PMC4939728. | en_US |
dc.identifier.eissn | 1462-0332 | |
dc.identifier.doi | 10.1093/rheumatology/kev311 | |
dc.identifier.pmid | 26342222 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12648/8287 | |
dc.description.abstract | To determine nephritis outcomes in a prospective multi-ethnic/racial SLE inception cohort. | |
dc.description.abstract | Patients in the Systemic Lupus International Collaborating Clinics inception cohort (≤15 months of SLE diagnosis) were assessed annually for estimated glomerular filtration rate (eGFR), proteinuria and end-stage renal disease (ESRD). Health-related quality of life was measured by the Short Form (36 questions) health survey questionnaire (SF-36) subscales, mental and physical component summary scores. | |
dc.description.abstract | There were 1827 patients, 89% females, mean (s.d.) age 35.1 (13.3) years. The mean (s.d.) SLE duration at enrolment was 0.5 (0.3) years and follow-up 4.6 (3.4) years. LN occurred in 700 (38.3%) patients: 566/700 (80.9%) at enrolment and 134/700 (19.1%) during follow-up. Patients with nephritis were younger, more frequently men and of African, Asian and Hispanic race/ethnicity. The estimated overall 10-year incidence of ESRD was 4.3% (95% CI: 2.8%, 5.8%), and with nephritis was 10.1% (95% CI: 6.6%, 13.6%). Patients with nephritis had a higher risk of death (HR = 2.98, 95% CI: 1.48, 5.99; P = 0.002) and those with eGFR <30 ml/min at diagnosis had lower SF-36 physical component summary scores (P < 0.01) and lower Physical function, Physical role and Bodily pain scores. Over time, patients with abnormal eGFR and proteinuria had lower SF-36 mental component summary (P ≤ 0.02) scores compared to patients with normal values. | |
dc.description.abstract | LN occurred in 38.3% of SLE patients, frequently as the initial presentation, in a large multi-ethnic inception cohort. Despite current standard of care, nephritis was associated with ESRD and death, and renal insufficiency was linked to lower health-related quality of life. Further advances are required for the optimal treatment of LN. | |
dc.language.iso | en | en_US |
dc.relation.url | https://academic.oup.com/rheumatology/article/55/2/252/1822307 | en_US |
dc.rights | © The Author 2015. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | inception cohort | en_US |
dc.subject | lupus | en_US |
dc.subject | nephritis | en_US |
dc.subject | outcomes research | en_US |
dc.subject | systemic lupus erythematosus | en_US |
dc.title | The frequency and outcome of lupus nephritis: results from an international inception cohort study. | en_US |
dc.type | Article/Review | en_US |
dc.source.journaltitle | Rheumatology (Oxford, England) | en_US |
dc.source.volume | 55 | |
dc.source.issue | 2 | |
dc.source.beginpage | 252 | |
dc.source.endpage | 62 | |
dc.source.country | United Kingdom | |
dc.source.country | United States | |
dc.source.country | United States | |
dc.source.country | United States | |
dc.source.country | England | |
dc.description.version | VoR | en_US |
refterms.dateFOA | 2023-02-07T17:20:25Z | |
html.description.abstract | To determine nephritis outcomes in a prospective multi-ethnic/racial SLE inception cohort. | |
html.description.abstract | Patients in the Systemic Lupus International Collaborating Clinics inception cohort (≤15 months of SLE diagnosis) were assessed annually for estimated glomerular filtration rate (eGFR), proteinuria and end-stage renal disease (ESRD). Health-related quality of life was measured by the Short Form (36 questions) health survey questionnaire (SF-36) subscales, mental and physical component summary scores. | |
html.description.abstract | There were 1827 patients, 89% females, mean (s.d.) age 35.1 (13.3) years. The mean (s.d.) SLE duration at enrolment was 0.5 (0.3) years and follow-up 4.6 (3.4) years. LN occurred in 700 (38.3%) patients: 566/700 (80.9%) at enrolment and 134/700 (19.1%) during follow-up. Patients with nephritis were younger, more frequently men and of African, Asian and Hispanic race/ethnicity. The estimated overall 10-year incidence of ESRD was 4.3% (95% CI: 2.8%, 5.8%), and with nephritis was 10.1% (95% CI: 6.6%, 13.6%). Patients with nephritis had a higher risk of death (HR = 2.98, 95% CI: 1.48, 5.99; P = 0.002) and those with eGFR <30 ml/min at diagnosis had lower SF-36 physical component summary scores (P < 0.01) and lower Physical function, Physical role and Bodily pain scores. Over time, patients with abnormal eGFR and proteinuria had lower SF-36 mental component summary (P ≤ 0.02) scores compared to patients with normal values. | |
html.description.abstract | LN occurred in 38.3% of SLE patients, frequently as the initial presentation, in a large multi-ethnic inception cohort. Despite current standard of care, nephritis was associated with ESRD and death, and renal insufficiency was linked to lower health-related quality of life. Further advances are required for the optimal treatment of LN. | |
dc.description.institution | SUNY Downstate | en_US |
dc.description.department | Rheumatology | en_US |
dc.description.degreelevel | N/A | en_US |
dc.identifier.journal | Rheumatology (Oxford, England) |